Angiotensin II activates a bumetanide sensitive increase in 86RB+ efflux in the rat heart

Res Commun Mol Pathol Pharmacol. 2000;107(1-2):89-104.

Abstract

We previously reported that alpha-adrenoceptor (AR) stimulation of the isolated perfused rat heart increased the efflux of 42K+ and the K+ analogue 86Rb+. The main part of this increase was bumetanide sensitive, indicating an activation of the Na+/K+/2Cl- cotransporter. The purpose of the present study was to investigate the effects of angiotensin II (1-100 nmol/l) and the protein kinase C (PKC) activator PMA (phorbol-12-myristate-13-acetate, 1-1000 nmol/l) on 86Rb+ efflux from isolated rat hearts and to compare the effects with the effect of the alpha1- AR agonist phenylephrine (30 micromol/l) in the presence of a beta-AR antagonist. Phenylephrine increased the 86Rb+ efflux rate by 47+/-4.1% (n=5, p<0.001). Angiotensin II induced a maximal increase in 86Rb+ efflux rate of 13+/-1.6% (n=12, p<0.0001). The effect of angiotensin II was totally eliminated by bumetanide (50 micromol/l). PMA decreased the 86Rb+ efflux rate by 23+/-7.0 % (n=7, p=0.02) and this effect of PMA was not sensitive to bumetanide. Pre-treatment of the hearts with PMA for 30 min did not influence the response to phenylephrine. In conclusion, angiotensin II stimulation, but not PKC activation by PMA increased the 86Rb+ efflux rate in isolated rat hearts, but the effect was smaller than that of alpha1- AR stimulation. The effect of angiotensin II was completely abolished by bumetanide indicating an activation of the Na+/K+/2Cl- -cotransporter.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology*
  • Angiotensin II / pharmacology*
  • Animals
  • Bumetanide / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Heart / drug effects*
  • In Vitro Techniques
  • Kinetics
  • Male
  • Myocardium / metabolism*
  • Phenylephrine / pharmacology
  • Phorbol 12,13-Dibutyrate / pharmacology*
  • Protein Kinase C / antagonists & inhibitors*
  • Rats
  • Rats, Wistar
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin / drug effects*
  • Rubidium Radioisotopes / metabolism*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin
  • Rubidium Radioisotopes
  • Bumetanide
  • Angiotensin II
  • Phenylephrine
  • Phorbol 12,13-Dibutyrate
  • Protein Kinase C